| 000 | 04436nam a22003735i 4500 | ||
|---|---|---|---|
| 999 |
_c106839 _d106839 _x1 |
||
| 001 | 106839 | ||
| 003 | ESmaUEC | ||
| 005 | 20230102113316.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 181102s2018 si | s |||| 0|eng d | ||
| 020 | _a9789811316999 | ||
| 024 | 7 |
_a10.1007/978-981-13-1699-9 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC |
||
| 050 | 4 |
_aQP86 _b2018 EB |
|
| 245 | 0 | 0 |
_aMolecular Basis and Emerging Strategies for Anti-aging Interventions _cedited by Syed Ibrahim Rizvi, Ufuk Çakatay |
| 264 | 1 |
_aSingapore _bSpringer Singapore _c2018 |
|
| 300 |
_a1 recurso en línea (XIV, 386 páginas) _b67 ilustraciones, 34 ilustraciones a color |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 0 | _aBiomedical and Life Sciences (Springer-11642) | |
| 505 | 0 | _aChapter 1. Hormesis and Hormetic drugs for healthy ageing and longevity -- Chapter 2. Intermittent fasting dietary restriction as a geroprotector.-Chapter 3. Anti-aging properties of Mediterranean diet components in human -- Chapter 4. Activation of plasma membrane redox system: A novel anti-aging strategy -- Chapter 5. Beneficial effects of alternate-day fasting and calorie restriction on the risk factors for age related diseases.-Chapter 6. Role of phytochemicals in eliciting longevity genes -- Chapter 7. Autophagy induction: A promising anti-aging strategy -- Chapter 8. The potential role of stem cell reprogramming in anti-aging -- Chapter 9. Anti-aging strategies based on telomerase activity -- Chapter 10. Epigenetic modification is an attractive target for therapeutic anti-aging intervention -- Chapter 11. Antioxidants for health and longevity -- Chapter 12. Current approaches of anti-inflammatory dependent anti-aging strategies -- Chapter 13. Anti-aging therapeutics based on rapalogs and mTOR inhibitors Exercise-induced anti-aging mechanisms -- Chapter 14. AMPK activation: An emerging anti-aging strategy -- Chapter 15. Sirtuin activators and brain aging -- Chapter 16. Glycolytic inhibitors as tools for developing caloric restriction mimetics -- Chapter 17. Novel classification perspective of geroprotective and senolytic drugs as an anti-aging strategy -- Chapter 18. The place of geroprotective agents in life quality and longevity of companion animals -- Chapter 19. Management of sarcopenia for successful aging -- Chapter 20. Impact of sarcopenia and sarcopenic obesity in healthy aging -- Chapter 21. Klotho levels may be an innovative approach for mitigating age-related diseases -- Chapter 22. Melatonin and its anti-aging activity. . | |
| 520 | 3 | _aThis book describes the nature of aging, age-related disorders, and the molecular principles of emerging strategies for anti-aging interventions, while also discussing the discovery of targets for geroprotective drugs. Although significant medical advances in the treatment and eradication of life-threatening conditions such as cardiovascular and infectious disease have been made over the past five decades, the prevalence of age-related disorders still remains high in older populations. Intervening into aging is the next frontier in contemporary medicine, and will be of increasing importance over time, as other sources of poor health are combated more and more successfully. Given the universal interest in anti-aging strategies, the book will appeal to a very broad audience. It addresses a diverse range of anti-aging interventions - including stem cells, autophagy, senolytics, anti-inflammatory methods, and telomerase induction - that will be of interest to scientists and researchers from various disciplines in the life sciences. . | |
| 650 | 7 |
_aEnvejecimiento _xAspectos geneticos _2embne _9141231 |
|
| 700 | 1 |
_aRizvi, Syed Ibrahim _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aÇakatay, Ufuk _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 |
_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _9106996 |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9789811316982 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811317002 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-1699-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 | _2lcc | ||
| 988 | _aEBSPRINGER_BIOMEDLIFE_2019 | ||
| 998 |
_aSI _a_alco _a_vill _b01/2019 _cm _dz _ef _feng _ggw _h0 |
||